GBI’s suite of biopharma intelligence products continues to grow with the introduction ofMETRIX, a comprehensive database that covers the entirety of the life science research sector. METRIX enables users to track and assess the impact of individual researchers and institutions, bringing clarity to the Chinese life science landscape with easy-to-use searchable tools. METRIX is the first available tool for locating and tracking scientific researchers and their work in China.
METRIX closely follows the progress of researchers, grants, universities, labs, medical institutions, published papers and patents, providing users the opportunity to zero in on trends, issues, and the most influential research leaders and institutions in any given therapeutic area. A key feature of METRIX is its customizable keyword and topic search functions that ensure complete and transparent analysis and analytics of any desired research landscape. As the importance of R&D continues to rise in China’s booming biopharma sector, METRIX will remain crucial in understanding and effectively participating in this emerging and important industry.